PEN Market Cap History
Below is a table of the PEN market cap history going back to 10/31/2015:

Date PEN Market Cap
10/31/20151.11B
1/31/20161.28B
4/15/20161.58B
7/15/20161.86B
10/15/20162.24B
1/31/20172.29B
4/14/20172.74B
7/18/20172.90B
10/17/20173.17B
2/13/20183.16B
4/24/20184.13B
7/24/20184.75B
10/24/20184.77B
2/12/20195.31B
4/23/20194.55B
7/23/20196.17B
8/2/20195.97B
10/24/20195.24B
2/11/20206.49B
4/21/20206.35B
7/20/20207.24B
10/19/20207.75B
2/9/202110.13B
4/12/20219.71B
7/20/20219.58B
10/21/202110.40B
2/14/20228.33B
4/19/20227.83B
7/21/20224.91B
10/20/20226.46B

Also see: PEN Shares Outstanding History
and PEN YTD Return
PEN Historical Market Cap:
+28.78% CAGR
PEN Historical Market Cap: +28.78% CAGR

Mouse over chart for data details
10/31/2015 ...10/20/2022
Penumbra is a healthcare company focused on therapies. Co. designs, develops, manufactures and markets products and has a portfolio that addresses various medical conditions. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Indigo System, which is designed for aspiration mechanical thrombectomy, utilizing the Penumbra System in ischemic stroke. Co.'s vascular products also include the Ruby Coil System, which consists of detachable coils that are designed for peripheral applications. We show 30 historical shares outstanding datapoints in our PEN shares outstanding history coverage, used to compute PEN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PEN market cap history over the course of time is important for investors interested in comparing PEN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PEN versus a peer is one thing; comparing PEN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PEN can fluctuate over the course of history. With this page we aim to empower investors researching PEN by allowing them to research the PEN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Penumbra (PEN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PEPG Market Cap History
PETV Market Cap History
PETX Market Cap History
PFE Market Cap History
PGEN Market Cap History
PGNX Market Cap History
PGNY Market Cap History
PHAS Market Cap History
PHAT Market Cap History
PHIO Market Cap History
More Healthcare companies »

 

PEN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.